Loading
Latest filing published 13 Feb 2026 for SCHOTT Pharma AG & Co. KGaA, €51k. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Reinhard Mayer in SCHOTT Pharma AG & Co. KGaA. Between 18 December 2025 and 12 February 2026, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (3 purchases, €140k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 1 purchase and no sales.
The median purchase comes to €45k.
The newest entry dates from 13 February 2026: an open-market purchase of €51k, in SCHOTT Pharma AG & Co. KGaA. Most trades are made public on the day they happen. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from BaFin. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations